Oxygenta Pharmaceutical Statistics

Total Valuation

BOM:524636 has a market cap or net worth of INR 1.95 billion. The enterprise value is 3.02 billion.

Market Cap	1.95B
Enterprise Value	3.02B

Important Dates

The last earnings date was Saturday, May 23, 2026.

Earnings Date	May 23, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:524636 has 36.98 million shares outstanding. The number of shares has increased by 2.91% in one year.

Current Share Class	36.98M
Shares Outstanding	36.98M
Shares Change (YoY)	+2.91%
Shares Change (QoQ)	+3.20%
Owned by Insiders (%)	29.68%
Owned by Institutions (%)	n/a
Float	4.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.72
PB Ratio	-4.57
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-17.20
EV / Sales	2.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.44

Financial Position

The company has a current ratio of 0.60

Current Ratio	0.60
Quick Ratio	0.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-2.70
Interest Coverage	-3.64

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-10.71%
Return on Invested Capital (ROIC)	-34.93%
Return on Capital Employed (ROCE)	-51.82%
Weighted Average Cost of Capital (WACC)	5.81%
Revenue Per Employee	6.47M
Profits Per Employee	-1.00M
Employee Count	175
Asset Turnover	1.12
Inventory Turnover	4.09

Taxes

Income Tax	-46.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.81% in the last 52 weeks. The beta is 0.52, so BOM:524636's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-44.81%
50-Day Moving Average	53.03
200-Day Moving Average	61.02
Relative Strength Index (RSI)	47.58
Average Volume (20 Days)	7,840

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524636 had revenue of INR 1.13 billion and -175.72 million in losses. Loss per share was -4.75.

Revenue	1.13B
Gross Profit	111.32M
Operating Income	-174.03M
Pretax Income	-221.80M
Net Income	-175.72M
EBITDA	-150.81M
EBIT	-174.03M
Loss Per Share	-4.75

Full Income Statement

Balance Sheet

The company has 21.49 million in cash and 1.10 billion in debt, with a net cash position of -1.07 billion or -29.04 per share.

Cash & Cash Equivalents	21.49M
Total Debt	1.10B
Net Cash	-1.07B
Net Cash Per Share	-29.04
Equity (Book Value)	-426.87M
Book Value Per Share	-11.27
Working Capital	-346.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -277.53 million and capital expenditures -128.57 million, giving a free cash flow of -406.10 million.

Operating Cash Flow	-277.53M
Capital Expenditures	-128.57M
Depreciation & Amortization	23.23M
Net Borrowing	473.34M
Free Cash Flow	-406.10M
FCF Per Share	-10.98

Full Cash Flow Statement

Margins

Gross margin is 9.83%, with operating and profit margins of -15.36% and -15.51%.

Gross Margin	9.83%
Operating Margin	-15.36%
Pretax Margin	-19.58%
Profit Margin	-15.51%
EBITDA Margin	-13.31%
EBIT Margin	-15.36%
FCF Margin	n/a

Dividends & Yields

BOM:524636 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.91%
Shareholder Yield	-2.91%
Earnings Yield	-9.02%
FCF Yield	-20.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2